AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease – The William M. Steinberg Board Review in Gastroenterology and Best Practices Course

LOG IN | PURCHASE | REGISTER FOR 2026 COURSE

You are currently viewing AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease

Post author:GIBoardReview.com
Post published:November 20, 2025
Post category:Society Guidelines

X